Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 110–110 | Cite as

Cisplatin/etoposide/irinotecan

Febrile neutropenia with pulmonary infection: case report
Case report
  • 5 Downloads

Reference

  1. Zhang L, et al. Comparison of the efficacy and safety of cisplatin, etoposide, and irinotecan combined with chemotherapy and topotecan monotherapy as second-line treatment for patients with sensitive relapsed SCLC. Chinese Journal of Clinical Oncology 46: 133-137, No. 3, 2019. Available from: URL: http://doi.org/10.3969/j.issn.1000-8179.2019.03.239 [Chinese; summarised from a translation] -China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations